Insomnia Market to reach US$4.0 bn by 2026, Says TMR

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
621
Insomnia Market to reach US$4.0 bn by 2026, Says TMR

Albany, NY, June 18, 2018 (GLOBE NEWSWIRE) -- TMR prophesies the global insomnia market to register a 6.6% CAGR during the forecast period 2017-2026. The market is anticipated to reach a valuation of US$4.0 bn by the completion of 2026. By sales channel, it could witness the rise of retail pharmacies and drug stores as a leading segment securing almost two-fifth of the total market share in the final forecast year. By region, North America is foreseen to take up the reins of the market until the end of the forecast period. In 2016, 70 mn adults in the U.S. suffered from insomnia, according to the Centers for Disease Control and Prevention (CDC).

Request to View Sample of Report - https://www.transparencymarketresearch.com/sa...p_id=20246

Excessive Consumption of Caffeine and Alcohol Influences Prevalence of Insomnia

Increased incidence of insomnia is predicted to raise more demand for effective treatments in the near term. Rising number of insomnia cases could be a result of smoking addiction and excessive caffeine and alcohol consumption. There has been a high focus on the development of innovative sleep-inducing medical devices and new technologies that could help in reducing symptoms of insomnia. This could also help to improve insomnia therapeutics to some extent.

Use of advanced technology to launch smart wearable sleep-inducers is projected to give a strong boost to the business of medical device manufacturers. Able to work with mobile apps, these devices are exclusively designed to help insomnia patients stay asleep for adequate period of time or fall asleep faster.

Request PDF Brochure of Report: https://www.transparencymarketresearch.com/sa...p_id=20246

Cost Sensitivity Prevails as Strong Challenge for Insomnia Drug Manufacturers

The issue of cost sensitivity is envisaged to create imbalance in the international insomnia market, even though a handful of players offer branded drugs. In this regard, the market could see novel molecules and new cost-effective chemical entities being developed by drug manufacturers so that they could improve their revenue earned in the market.

Request For Discount On This Report : https://www.transparencymarketresearch.com/sa...p_id=20246

Soaring stress levels of working individuals and unnatural work timings in emerging regions such as Asia Pacific could create opportunities in the international insomnia market. Moreover, government initiatives to improve healthcare system are foretold to support market growth in the foreseeable future. Swelling healthcare expenditure in North America, on the other hand, could also propel growth in the near future.

The global insomnia market is prognosticated in a publication by Transparency Market Research (TMR) to find players concentrating on the development of effective treatment methods with new drug formulations and continuous research and development investment. There could hardly be any drugs available that provide complete treatment of insomnia. This is expected to open the door to profit-making opportunities as companies come up with a series of drugs for short-term treatment, including zolpidem, trazodone, and tricyclic antidepressants (TCAs). The market sees strong opportunities for innovation and development due to lack of absolute treatment for insomnia. Pfizer Inc., Sanofi, and Merck & Co. are among key players of the market.

More Trending Reports by Transparency Market Research:

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Mr. Nachiket Ghumare Transparency Market Research State Tower 90 State Street, Suite 700, Albany, NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email : sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Research Blog: http://theglobalhealthnews.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

uniQure N.V. Under Investigation: What Shareholders Should Know

Updated Category News Views 124

Understanding the Investigation into uniQure N.V. In a recent development, Bragar Eagel & Squire, P.C., a law firm recognized nationally for its stockholder rights advocacy, has launched an investigation into uniQure N.V. (NASDAQ: QURE). The firm aims to determine whether uniQure has potentially violated federal securities laws or engaged in other unlawful business...

Continue Reading
Rocket Lab vs Intuitive Machines: Who Will Dominate Space in 2025?

Updated Category News Views 716

Rocket Lab vs Intuitive Machines: Who Will Win in 2025? At the forefront of space exploration, Intuitive Machines Inc (NASDAQ: LUNR) is preparing to launch its second Commercial Lunar Payload Services (CLPS) mission. This time, it will deliver NASA's PRIME-1 drill to the Moon, marking another significant step in their lunar exploration endeavors. Since their historic...

Continue Reading
Dr. Johney Green Jr. Takes Leadership Role at SRNL Lab

Updated Category News Views 446

Dr. Johney Green Jr. Appointed as Laboratory Director Dr. Johney Green Jr. has been chosen to lead the Savannah River National Laboratory (SRNL) as the new Laboratory Director. With a robust background as the Associate Laboratory Director for mechanical and thermal engineering sciences at the National Renewable Energy Laboratory (NREL), he brings a wealth of experience to...

Continue Reading
TRAY and PrimePay Join Forces for Enhanced POS and Workforce Solutions

Updated Category News Views 120

TRAY and PrimePay Partnership: A Breakthrough in Hospitality Technology In an exciting development within the hospitality sector, TRAY, recognized as a global leader in cloud-native enterprise-class POS systems, has cemented a strategic partnership with PrimePay, an expert in human capital management (HCM) SaaS solutions. This collaboration is set to revolutionize the way...

Continue Reading
Kemper Corporation Boosts Quarterly Dividend to $0.32 Per Share

Updated Category News Views 82

Kemper Corporation Increases Dividend for Shareholders Kemper Corporation (NYSE: KMPR) has announced an exciting development for its investors. The company's Board of Directors has officially declared an increase in the quarterly dividend to $0.32 per share. This marks a notable 3.1% rise, amounting to an additional cent over the previously set amount. Consequently, the...

Continue Reading